PDE8B is a human gene whose product pDE8B plays several essential roles in neuronal function:. Variants in PDE8B have been implicated in Early-Onset Parkinson's Disease, Spinocerebellar Ataxia, Additional Associations. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
PDE8B (Phosphodiesterase 8B) encodes a high-affinity cyclic adenosine monophosphate (cAMP) phosphodiesterase enzyme that plays a critical role in regulating intracellular cAMP signaling in neurons, particularly in the striatum. Rare variants in PDE8B are associated with early-onset Parkinson's disease and striatal degeneration, making it an important gene in understanding dopaminergic neuron vulnerability[1][2].
The PDE8B gene is located on chromosome 5q31.1 and encodes the PDE8B enzyme, one of several phosphodiesterase families that hydrolyze cAMP. Unlike other phosphodiesterases, PDE8B has high affinity for cAMP, making it particularly important in tissues with low cAMP concentrations such as the striatum[3].
| Property | Value |
|---|---|
| Gene Symbol | PDE8B |
| Chromosomal Location | 5q31.1 |
| NCBI Gene ID | 27107 |
| UniProt ID | O76074 |
| Protein Family | Phosphodiesterase 8 family |
| Tissue Expression | Striatum, cortex, cerebellum, adrenal gland |
PDE8B plays several essential roles in neuronal function:
PDE8B hydrolyzes cAMP, thereby terminating cAMP-mediated signaling cascades. In neurons, cAMP is a critical second messenger that regulates:
The striatum (caudate nucleus and putamen) has the highest PDE8B expression in the brain. Here, PDE8B regulates:
PDE8B modulates dopaminergic signaling by controlling cAMP levels in striatal neurons. This affects:
Rare missense mutations in PDE8B cause a distinct form of early-onset parkinsonism characterized by[4][5]:
The mechanism involves loss of PDE8B function, leading to elevated cAMP levels that may paradoxically cause neuronal dysfunction through excessive PKA activation.
PDE8B variants have been implicated in autosomal recessive cerebellar ataxias, affecting:
PDE8B exhibits a distinctive expression pattern in the human brain:
| Brain Region | Expression Level |
|---|---|
| Striatum (caudate/putamen) | Very High |
| Cerebral cortex | Moderate |
| Cerebellum | Moderate |
| Hippocampus | Low |
| Substantia nigra | Low |
| Adrenal gland | Very High |
The high striatal expression explains the selective vulnerability of striatal neurons in PDE8B-associated parkinsonism.
PDE8B is a potential therapeutic target for neurodegenerative diseases[6]:
Selective PDE8 inhibitors are being developed for: